Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 1840 for “"Drug development"”.
-
Governance of Drug Development Alliances
… (hereafter, biotechs or biotech firms) consider drug development alliances with incumbent pharmaceutical firms (hereafter, pharmas or pharma firms) as a means to access complementary commercialization capabilities, enhance their managerial skillset through close interactions, and maintain …
-
Managing Incentives in Drug Development
… commercial incentives are too weak to support drug development, while for advanced and rare-disease treatments, regulators must make approval decisions under severe uncertainty and limited benchmarks. This dissertation adopts a mechanism design framework to analyze these distinct but related …
-
Drug development against kinetoplastid parasites
… many problems are associated with it, including drug toxicity, resistance, lack of guaranteed supply, and high treatment cost. Therefore, there is an urgent need for new treatment approaches. Here, we aim to examine the in vitro efficacy of curcumin and phosphonium compounds against these …
-
Process hazard review for drug development
The development of drugs has become increasingly complex, requiring the use of a wide variety of pharmaceutical actives and isolated intermediates, a majority of which are not always completely characterized with respect to their hazard potential. This can present a source of potential exposure to …
-
Essays on Drug Development and Marketing
… consists of three chapters relating to drug development and marketing strategies. Chapter 1 studies strategic direct-to-consumer and direct-to-physician advertising in the pharmaceutical industry. Chapter 2 examines the strategic interaction between government agencies in funding support …
-
Automated experiment design for drug development
Testing drugs in discovery is time consuming and expensive. An idea is then to eliminate unpromising compounds from the testing phase by using online learning methods to predict properties of yet to be tested compounds and determining which drugs to test. This is done by comparing substructures in …
-
Therapeutic Vaccine and Drug Development for Gynecologic Cancers
… thereby limiting its utility for pre-clinical development of vaccines. Here, we establish persistent MmuPV1 papillomas in outbred and immune competent SKH1-Elite mice (Crl:SKH1-Hrhr) as a promising model to study potential immunotherapies for PV-related disease and the relationship between …
-
The Genetics of Cancer in Pharmacological Drug Development
The field of cancer therapeutic development has been dominated by two research and discovery paradigms, the cytotoxicity-based or phenotype driven strategy and the target-based rational approach. This thesis describes the standardization of novel assays used in both approaches and the discoveries …
-
Targeting schistosome cholinesterases for vaccine and drug development
… has been successfully targeted by anthelmintic drugs but the use of many of these has discontinued because of toxic side effects and so there is a need to better understand key neuronal processes at a molecular level to develop safer and more effective intervention strategies that target this …
-
A Three Dimensional Scaffold for Anticancer Drug Development
Attrition rates for anticancer drugs are much higher than any other therapeutic area. Only 5%#37; of the agents that demonstrate anticancer activity in the preclinical stages of development demonstrate clinical efficacy in phase III trials. This high attrition rate becomes alarming when we consider …
-
Unsupervised Learning of Molecular Representations for Drug Development
… to the field of chemistry and pharmaceutical drug development in particular. Recently, there has been a surge of interest in using machine learning to predict molecular properties such as the binding affinity to protein targets of interest or to generate molecular structures with desirable …
-
Genetically engineered mouse models in preclinical drug development
… facilitate the study of mechanisms underpinning drug resistance. Using the BLG--HER2KI-PTEN+/- model, we demonstrated that Src plays an important role in the early stages of tumour development. Chemopreventative treatment with dasatinib delayed tumour inititation (p= 0.046, Wilcoxon signed rank …
-
Pharmacokinetics & paediatric antiretroviral drug development - closing the gap
Contains fulltext : 277202.pdf (Publisher’s version ) (Open Access)
-
APPLICATION OF MACHINE LEARNING APPROACHES TO EMPOWER DRUG DEVELOPMENT
… antimicrobials, are in urgent need. However, the drug development process is long, complex, and risky with no guarantee of success. Also, the improvements in techniques applied in genomics, proteomics, computational biology, and clinical trials significantly increase the data complexity and …
-
Application of Pharmacometric Methods to Improve Pediatric Drug Development
… that is rapidly changing the landscape of drug development, and particularly so for the pediatric population. The motivation behind the research underlying this dissertation is to contribute towards the improvement of pediatric drug development by the astute application of pharmacometric …
-
Protein and Ligand Dynamics in Drug Development and Resistance
… therapeutics. In this work, we describe the development and implementation of novel techniques to study dynamics in proteins and protein-bound ligands, and discuss our investigation of the crucial role of dynamics in two disease-relevant systems.</p><p>First, we have expanded the utility of …
-
Functional Connectivity and Machine Learning for Psychiatric Drug Development
The human brain is a complex biological network consisting of spatially separated but functionally integrated regions. Study of functional connectivity gained immense popularity in recent years providing new insight into the mechanisms underlying complex functions and the fundamental organisation …
-
The persistence and burden of failing drug development paradigms
Background: Failures in cancer drug development impose heavy burdens on patients, researchers, industry, and funders. Burdens in targeted drug development could be mitigated if investigators efficiently integrated not only trial outcomes, but also evidence for underlying pathophysiological …
Page 1 of 92